Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Gyrodyne, LLCGYRO · Entity 7938 | Director | March 12, 2024 | August 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Gyrodyne, LLC
Report date March 12, 2024 · Filed August 27, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC Table I · non-derivative | Direct | 30,441 |
Reported balance
After 2024-03-12 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2024-03-12 · Other · Acquired 8,698 · Balance 30,441 F1: Acquired shares through exercise of rights pursuant to rights offering of the issuer F2: Corrected the number of shares acquired in this Form 4 F3: Corrected the number of shares beneficially owned in this Form 4 |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired shares through exercise of rights pursuant to rights offering of the issuer
F2: Corrected the number of shares acquired in this Form 4
F3: Corrected the number of shares beneficially owned in this Form 4
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2024 Filed Mar 14, 2024 13:18 UTC | Gyrodyne, LLC GYRO · Entity 7938 | OtherCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTS | 8,672 | $8.00 | $69,376.00 |
DisclosureSEC source: 0001246739-24-000001 · primary_doc.xml · nonDerivative · entry 1 MACKLIN RONALD J · CIK 0001246739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,415 F1 · kind: Acquired shares through exercise of rights pursuant to rights offering of the issuer Read SEC document |
| March 12, 2024 Filed Aug 27, 2025 11:12 UTC Amendment | Gyrodyne, LLC GYRO · Entity 7938 | OtherCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTS | 8,698 | $8.00 | $69,584.00 |
DisclosureSEC source: 0001246739-25-000003 · primary_doc.xml · nonDerivative · entry 1 MACKLIN RONALD J · CIK 0001246739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,441 F1 · kind: Acquired shares through exercise of rights pursuant to rights offering of the issuer F2 · shares: Corrected the number of shares acquired in this Form 4 F3 · balance_after: Corrected the number of shares beneficially owned in this Form 4 Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 11:37 UTC | Gyrodyne, LLC GYRO · Entity 7938 | GrantCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTS | 20,362 | $21.60 | $439,819.20 |
DisclosureSEC source: 0001246739-23-000002 · primary_doc.xml · nonDerivative · entry 1 MACKLIN RONALD J · CIK 0001246739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,743 F1 · shares: The Reporting Person agreed to waive his benefits under the Issuer's Bonus Plan, and receive in exchange shares of equivalent value under the Issuer's Stock Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.